Drug Guide

Generic Name

Doxylamine Succinate and Pyridoxine Hydrochloride

Brand Names Diclegis, Bonjesta

Classification

Therapeutic: Antiemetic for nausea and vomiting during pregnancy

Pharmacological: Antihistamine (Doxylamine), Vitamin B6 supplement (Pyridoxine)

FDA Approved Indications

Mechanism of Action

Doxylamine is an antihistamine that relieves nausea by blocking H1 histamine receptors, and Pyridoxine (vitamin B6) is involved in amino acid metabolism and neurotransmitter synthesis, which helps reduce nausea.

Dosage and Administration

Adult: Typically, 10 mg of Doxylamine and 10-25 mg of Pyridoxine at bedtime or divided throughout the day. Specific dosing depends on the formulation and patient response.

Pediatric: Not established for pediatric use; consult healthcare provider.

Geriatric: Use with caution; start at lower doses due to increased sensitivity and risk of side effects.

Renal Impairment: Adjust dose based on severity of impairment.

Hepatic Impairment: Use caution; no specific adjustments established.

Pharmacokinetics

Absorption: Well absorbed from gastrointestinal tract.

Distribution: Widely distributed; crosses blood-brain barrier.

Metabolism: Hepatic metabolism for Doxylamine; Pyridoxine metabolized in the liver.

Excretion: Renal excretion of metabolites.

Half Life: Doxylamine approximately 10 hours; Pyridoxine approximately 25-33 hours.

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

N/A

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor for signs of excessive sedation, anticholinergic effects, and pregnancy symptoms.

Diagnoses:

  • Risk for injury related to sedation
  • Risk for falls in elderly

Implementation: Administer at recommended doses, assess patient response, and educate on sedation precautions.

Evaluation: Efficacy in reducing nausea, minimal adverse effects.

Patient/Family Teaching

Special Considerations

Black Box Warnings:

Genetic Factors: Genetic variations in metabolism may affect drug levels.

Lab Test Interference: None reported.

Overdose Management

Signs/Symptoms: Extreme drowsiness, confusion, hallucinations, anticholinergic effects, potentially coma.

Treatment: Supportive care, activated charcoal if within 1 hour of ingestion, airway management, and symptomatic treatment.

Storage and Handling

Storage: Store at room temperature, away from moisture and light.

Stability: Stable under normal conditions.

This guide is for educational purposes only and is not intended for clinical use.